Provided by Tiger Trade Technology Pte. Ltd.

GlaxoSmithKline PLC

47.02
+0.42000.90%
Post-market: 47.240.2200+0.47%19:30 EDT
Volume:5.85M
Turnover:275.58M
Market Cap:95.11B
PE:15.04
High:47.41
Open:46.92
Low:46.69
Close:46.60
52wk High:61.70
52wk Low:42.85
Shares:2.02B
Float Shares:1.94B
Volume Ratio:0.99
T/O Rate:0.30%
Dividend:1.80
Dividend Rate:3.82%
EPS(TTM):3.13
EPS(LYR):3.74
ROE:33.38%
ROA:10.01%
PB:4.08
PE(LYR):12.58

Loading ...

Berenberg Bank Keeps Their Buy Rating on GlaxoSmithKline (GSK)

TIPRANKS
·
Yesterday

Barclays Remains a Sell on GlaxoSmithKline (GSK)

TIPRANKS
·
Yesterday

Why Vaxcyte Chose A 1.5% Convertible

Macro World​
·
Yesterday

GSK's ViiV Healthcare Says HIV Treatment Cabenuva's Latest Trial Meets Primary Endpoint

MT Newswires Live
·
Oct 06

GSK’s ViiV Healthcare announces phase IIIb CROWN study met primary endpoint

TIPRANKS
·
Oct 06

From Lilly Deal to Market Darling: Inside Ginkgo's 120% Monthly Run

Bellwether Stocks Movement
·
Oct 06

GSK Slides Monday, Underperforms Market

Dow Jones
·
Oct 06

European Equities Traded in the US as American Depositary Receipts Track Lower in Monday Trading

MT Newswires Live
·
Oct 05

One Molecule, Three Diseases, $1.55 Billion — Inside CSL's Bet

Bellwether Stocks Movement
·
Oct 05

Merck Doubled Off Its Lows — And Analysts Still See More Room

Bellwether Stocks Movement
·
Oct 05

CSL Bets $1.6 Billion on a Drug That Hasn't Finished Phase 2

Bellwether Stocks Movement
·
Oct 05

Bayer Bets $2.2 Billion That America Is Still The Best Place To Make Drugs

Macro World​
·
Oct 03

23.3% Vs 14.8%: Lilly's New Data Just Changed The Obesity Drug Playbook

Bellwether Stocks Movement
·
Oct 03

Novartis Bets $7.8 Billion On MRNA Beyond Vaccines

Options & Short Sell
·
Oct 02

GlaxoSmithKline (GSK) Gets a Sell from J.P. Morgan

TIPRANKS
·
Oct 01

GSK Slides Wednesday, Underperforms Market

Dow Jones
·
Oct 01

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading

MT Newswires Live
·
Sep 30

Jefferies Remains a Buy on GlaxoSmithKline (GSK)

TIPRANKS
·
Sep 29

$20 Billion In Deals And Counting: Lilly's CEO Targets The "White Space" Of Science For Larger M&A

Options & Short Sell
·
Sep 29

AstraZeneca To Invest $2 Billion In Summit And Co-Develop Drugs; Shares Jump After Hours

Options & Short Sell
·
Sep 29